EuroIntervention 2015;10:1187-1194 published online ahead of print May 2014. DOI: 10.4244/EIJY14M05_11
Aims: The objective of this study was to analyse the outcomes of patients treated with high-bolus dose (HBD) tirofiban compared with abciximab at the time of primary PCI (PPCI) for ST-ele
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com